Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection

Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection

The SARS-CoV-2 pandemic is continuing to impact the global population, and knowledge of the immune response to COVID-19 is still developing. This study assesses the interplay of different parts of the immune system during COVID-19 disease.

Bibliographic Details
Main Authors: Alexander M. Horspool, Theodore Kieffer, Brynnan P. Russ, Megan A. DeJong, M. Allison Wolf, Jacqueline M. Karakiozis, Brice J. Hickey, Paolo Fagone, Danyel H. Tacker, Justin R. Bevere, Ivan Martinez, Mariette Barbier, Peter L. Perrotta, F. Heath Damron
Format: Article
Language:English
Published: American Society for Microbiology 2021-02-01
Series:mSphere
Online Access:https://journals.asm.org/doi/10.1128/mSphere.01324-20

Internet

https://journals.asm.org/doi/10.1128/mSphere.01324-20

Similar Items